icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
The Liver Meeting
November Fri, Nov 10, 2023 - Mon, Nov 14, 2023


 
Back grey_arrow_rt.gif
 
 
 
Towards ultra-short DAA therapy to eradicate HCV infection?
 
 
  AASLD 2023 Nov 10-14
 

 
https://www.aasld.org/the-liver-meeting
 
A. Grassi1,2, N. Celli1, S. Maccariello1, G. Donati1, A. Fabbri1, G. Ballardini1 1Division of Internal Medicine and Hepatology, Infermi Hospital, Rimini, AUSL Romagna, Italy 2Division of Internal Medicine, Cervesi Hospital, Cattolica (RN), AUSL Romagna, Italy

1113231

Premise
 
There is general agreement about the fact that at least 8 weeks of direct anti-viral (DAA) therapy are necessary to achieve definitive HCV eradication. Nevertheless, nowadays, the real impact of DAA in HCV replication is probably not yet completely known.

1113232

1113233